Back to Journals » Clinical Epidemiology » Volume 4 » Supplement 2 Cancer staging

Completeness of colon and rectal cancer staging in the Danish Cancer Registry, 2004–2009

Authors Eva Bjerre Ostenfeld EB, Froeslev T, Friis S, Gandrup, Madsen, Søgaard M

Received 28 March 2012

Accepted for publication 1 May 2012

Published 17 August 2012 Volume 2012:4(Supplement 2 Cancer staging) Pages 33—38

DOI https://doi.org/10.2147/CLEP.S32362

Review by Single anonymous peer review

Peer reviewer comments 2



Eva Bjerre Ostenfeld,1,2 Trine Frøslev,1 Søren Friis,3 Per Gandrup,2 Mogens Rørbæk Madsen,4 Mette Søgaard1,5

1
Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark; 2Department of Surgery A, Aarhus University Hospital, Aalborg, Denmark; 3Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark; 4Department of Surgery A, Herning Regional Hospital, Herning, Denmark; 5Department of Clinical Microbiology, Aarhus University Hospital, Aalborg, Denmark

Objective: To explore the completeness of tumor, node, metastasis (TNM) staging for colon and rectal cancer in the Danish Cancer Registry.
Material and methods: From the Danish Cancer Registry, we retrieved data on TNM stage, year of diagnosis, sex, and age for 15,976 and 8292 patients, respectively, with first diagnoses of colon or rectal cancer during the 2004–2009 period. From the Danish National Patient Register, we retrieved data on comorbidity (computed as Charlson Comorbidity Index scores). We calculated the completeness of TNM staging overall, by each stage component, and according to a stage algorithm allowing some missing stage components. Analyses were stratified by sex, age, year of diagnosis, and Charlson Comorbidity Index score.
Results: For colon and rectal cancer, overall TNM completeness was 67.8% (95% confidence interval [CI]: 67.0%–68.5%) and 68.1% (95% CI: 67.0%–69.1%), respectively. For both cancers, completeness decreased with increasing age and level of comorbidity, whereas differences between the sexes were minor. Over the study period, TNM completeness for colon cancer decreased from 71.3% (95% CI: 69.5%–73.0%) to 64.8% (95% CI: 63.0%–66.6%), whereas the completeness for rectal cancer remained stable over time. When using the stage algorithm, the completeness rose markedly, to 81.1% for colon cancer and 79.0% for rectal cancer.
Conclusion: One-third of colon and rectal cancer cases in the Danish Cancer Registry had missing TNM stage information, which varied with age and level of comorbidity. Cancer cases with unknown staging warrant serious consideration of the methodological implications in future epidemiological studies monitoring cancer incidence and outcomes.

Keywords: colorectal neoplasm, neoplasm staging, TNM, registries, epidemiology, cancer

Creative Commons License © 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.